论文著作：
1. Jing Wang, Yangsa Du, Guoting Su, Weiting Tang, Yongju He* and Li Feng*. Dual-functionalpH-sensitive nanoliposome modified with CD47 mimicy peptide enhance icariin delivery to attenuate neuoinflammation and oxidative stress in epilepsy. Mterial Today Bio 2025, 35: 102528.
2. Meiru Zhang, Hui Xu, Xiaozan Wu, Botao Chen, Xiyu Gong, and Yongju He*. Engineering Dual-Responsive Nanoplatform Achieves Copper Metabolism Disruption and Glutathione Consumption to Provoke Cuproptosis/Ferroptosis/Apoptosis for Cancer Therapy. ACS Appl. Mater. Interfaces 2025, 17: 20726-20740.
3. Yongju He, Meiru Zhang, Xiyu Gong, Xiaoxuan Liu, Fangfang Zhou, and Binbin Yang. Diselenide-Bridged Mesoporous Silica-Based Nanoplatform with a Triple ROS-Scavenging Effect for Intracerebral Hemorrhage Treatment. ACS Appl. Mater. Interfaces 2024, 16: 40739-40752.
4. Yongju He, Xiangjie Tian, Meiru Zhang, Hui Xu, Xiyu Gong, Binbin Yang and Fangfang Zhou. Fenton-like nanoparticles capable of H2O2 self-supply and glutathione consumption for chemodynamic and chemotherapy of cancer. Biomater. Sci. 2024, 12: 5534-5546.
5. Yongju He*, Xiangjie Tian, Xingyu Fan, Xiyu Gong, Songwen Tan, Anqiang Pan, Shuquan Liang, Hui Xu, and Fangfang Zhou. Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy. ACS Appl. Mater. Interfaces 2023, 15: 552-565.
6. Xiangjie Tian, Hui Xu, FangFang Zhou, Xiyu Gong, Songwen Tan and Yongju He*. An Intelligent Cupreous Nanoplatform with Self-Supplied H2O2 and Cu2+/Cu+ Conversion to Boost Cuproptosis and Chemodynamic Combined Therapy. Chem. Mater. 2024, 36(2): 815-828.
7. Guoting Su, Hui Xu, FangFang Zhou, Xiyu Gong, Songwen Tan and Yongju He*. Boosting reactive oxygen species generation with a dual-catalytic nanomedicine for enhanced tumor nanocatalytic therapy. ACS Appl. Mater. Interfaces 2023, 15: 59175-59188.
8. Mingzhe Liu, Hui Xu, FangFang Zhou, Xiyu Gong, Songwen Tan and Yongju He*. A tetrasulfide bond-bridged mesoporous organosilica-based nanoplatform for triple-enhanced chemodynamic therapy combined with chemotherapy and H2S therapy. J. Mater. Chem. B 2023, 11: 10822-10835.
9. Xingyu Fan, Botao Chen, Hui Xu, Anqiang Pan, Shuquan Liang, Songwen Tan, and Yongju He*.Glutathione/Glucose-Depleting Nanoparticles with NO Generation for Ferroptosis/Starvation/NO-Induced Cancer Therapy. Chem. Mater. 2023, 35: 3124-3137.
10. Taishun Hu, Xiyu Gong, Xinli Liu, Hui Xu, Fangfang Zhou, Songwen Tan and Yongju He*. Smart design of a therapeutic nanoplatform for mitochondria-targeted copper-depletion therapy combined with chemotherapy. J. Mater. Chem. B 2023, 11: 8433-8448.
11. Yongju He*, Xingyu Fan, Xiaozan Wu, Taishun Hu, Fangfang Zhou, Songwen Tan, Botao Chen*, Anqiang Pan, Shuquan Liang and Hui Xu. pH-responsive size-shrinkable mesoporous silica-based nanocarriers for improving tumor penetration and therapeutic efficacy. Nanoscale 2022, 14: 1271-1284.
12. Xingyu Fan, Xiyu Gong, Fangfang Zhou, Botao Chen, Songwen Tan, Hui Xu, Anqiang Pan , Shuquan Liang and Yongju He*. Mesoporous peroxidase nanozyme for synergistic chemodynamic therapy and chemotherapy. Colloids and Surfaces B: Biointerfaces 2022, 216: 112603.
13. Linjie Shao, Taishun Hu, Xingyu Fan, Xiaozan Wu, Fangfang Zhou, Botao Chen, Songwen Tan, Hui Xu, Anqiang Pan, Shuquan Liang and Yongju He*. Intelligent nanoplatform with multi therapeutic modalities for synergistic cancer therapy. ACS Appl. Mater. Interfaces 2022, 14: 13122-13135.
14. Yao Hu, Song Bai, Xingyu Fan,a Fangfang Zhou, Botao Chen, Songwen Tan, Hui Xu, Anqiang Pan, Shuquan Liang and Yongju He*. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H2O2-dependent chemodynamic therapy. Biomater. Sci. 2022, 10: 2358-2369.
………
何勇菊
湖南省
研究领域：
生物医药
研究方向：
多功能纳米材料、纳米生物医药材料、智能纳米药物载体、纳米药物递送系统及纳米药物的设计与开发等 医工交叉“新工科、新医科”前沿领域的基础与应用
所在单位：
中南大学
